OTCMKTS:IPIX - Innovation Pharmaceuticals SEC Filings & 10K Form

$0.1640
-0.02 (-8.84 %)
(As of 07/16/2019 04:00 PM ET)
Today's Range
$0.16
Now: $0.1640
$0.1740
50-Day Range
$0.1625
MA: $0.20
$0.25
52-Week Range
$0.07
Now: $0.1640
$0.62
Volume335,991 shs
Average Volume494,506 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

SEC Filings

Innovation Pharmaceuticals (OTCMKTS:IPIX) SEC Filings

DateFilerForm TypeView
05/16/2019
9:15 AM
Innovation Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/10/2019
4:16 PM
Innovation Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
05/10/2019
6:32 AM
Innovation Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/10/2019
6:31 AM
Innovation Pharmaceuticals (Filer)
Form 424B5
View Filing
02/08/2019
3:01 PM
Innovation Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
01/31/2019
3:16 PM
EHRLICH LEO (Reporting)
Innovation Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/31/2019
3:15 PM
Innovation Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/22/2019
11:06 AM
Aruda Wayne O (Filed by)
Innovation Pharmaceuticals (Subject)
Form SC 13G/A
View Filing
01/07/2019
3:30 PM
Innovation Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/18/2018
4:00 PM
Innovation Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/17/2018
6:05 AM
Innovation Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/17/2018
6:00 AM
Innovation Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/13/2018
6:15 AM
Innovation Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/08/2018
4:01 PM
Innovation Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
10/24/2018
6:00 AM
Innovation Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/16/2018
3:15 PM
Harness Jane A. (Reporting)
Innovation Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
10/15/2018
5:18 PM
Bertolino Arthur Peter (Reporting)
Innovation Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
10/10/2018
9:55 AM
Innovation Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/09/2018
5:52 AM
Innovation Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/09/2018
5:51 AM
Innovation Pharmaceuticals (Filer)
Form 424B5
View Filing
09/24/2018
3:32 PM
Bertolino Arthur Peter (Reporting)
Innovation Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/24/2018
3:26 PM
Harness Jane A. (Reporting)
Innovation Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/21/2018
3:01 PM
Innovation Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
09/11/2018
3:01 PM
Innovation Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
View Filing
06/29/2018
6:23 AM
Innovation Pharmaceuticals (Filer)
Form 424B5
View Filing
05/10/2018
3:06 PM
Innovation Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
04/16/2018
12:16 PM
Innovation Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/09/2018
2:02 PM
Innovation Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/11/2018
3:34 PM
Aruda Wayne O (Filed by)
Innovation Pharmaceuticals (Subject)
Form SC 13G/A
View Filing
12/27/2017
2:07 PM
Bertolino Arthur Peter (Reporting)
Innovation Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
This page was last updated on 7/16/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel